Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (271-280 of 449) with videos related to

Pageof 45
Sort By:
International Journal of Pharmaceutics: X|November 19, 2025
Engineered extracellular vesicles demonstrate altered endocytosis and biodistribution and have superior oral siRNA delivery efficiency compared to lipid nanoparticlesNing Ding, Armond Daci, Vanesa Krasniqi, et al.
Sensors (Basel, Switzerland)|January 10, 2026
High-Accuracy Indoor Positioning and Smart Home Technologies for Assessing and Monitoring Frailty in Older AdultsAntonio Miguel Cruz, Mathieu Figeys, Yusuf Ahmed, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders|September 19, 2025
Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlookLuisa Klotz, Thomas Berger, Wallace J Brownlee, et al.
Therapeutic Advances in Neurological Disorders|July 19, 2023
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi methodRalf Gold, Michael Barnett, Andrew Chan, et al.
Archives of Neurology|February 16, 2011
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosisOlaf Stüve, Joanne Wang, Andrew Chan, et al.
European Journal of Neurology|February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literatureAlejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics|August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey studyLara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Cancers|February 10, 2024
The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer DevelopmentRui Dai, Bridget N Kelly, Amarachi Ike, et al.
Pageof 45

Showing results (271-280 of 449) with videos related to

Sort By:
Pageof 45
International Journal of Pharmaceutics: X|November 19, 2025
Engineered extracellular vesicles demonstrate altered endocytosis and biodistribution and have superior oral siRNA delivery efficiency compared to lipid nanoparticlesNing Ding, Armond Daci, Vanesa Krasniqi, et al.
Sensors (Basel, Switzerland)|January 10, 2026
High-Accuracy Indoor Positioning and Smart Home Technologies for Assessing and Monitoring Frailty in Older AdultsAntonio Miguel Cruz, Mathieu Figeys, Yusuf Ahmed, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders|September 19, 2025
Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlookLuisa Klotz, Thomas Berger, Wallace J Brownlee, et al.
Therapeutic Advances in Neurological Disorders|July 19, 2023
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi methodRalf Gold, Michael Barnett, Andrew Chan, et al.
Archives of Neurology|February 16, 2011
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosisOlaf Stüve, Joanne Wang, Andrew Chan, et al.
European Journal of Neurology|February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literatureAlejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics|August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey studyLara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Cancers|February 10, 2024
The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer DevelopmentRui Dai, Bridget N Kelly, Amarachi Ike, et al.
Pageof 45